首页 News 正文

On April 25th, AstraZeneca announced its financial results for the first quarter of 2024: total revenue was $12.679 billion, a year-on-year increase of 19%; Core earnings per share were $2.06, a year-on-year increase of 13%.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

芊芊551 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    44